GRAIL, Inc. (GRAL) is in Healthcare, Diagnostics & Research, based in United States, listed on NasdaqGS. Market cap 5.92B USD. 52-week range 41.50 to 166.47 USD. Data as of 2026-10-09.
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and ...